TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 80 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2014. The put-call ratio across all filers is 5.00 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $324,000 | +0.3% | 2,878 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $323,000 | -27.3% | 2,878 | -24.4% | 0.00% | -50.0% |
| Q1 2017 | $444,000 | -7.1% | 3,808 | -16.1% | 0.00% | 0.0% |
| Q4 2016 | $478,000 | -70.3% | 4,538 | -68.8% | 0.00% | -71.4% |
| Q3 2016 | $1,607,000 | -24.1% | 14,538 | 0.0% | 0.01% | -22.2% |
| Q2 2016 | $2,117,000 | +491.3% | 14,538 | +481.1% | 0.01% | +350.0% |
| Q1 2016 | $358,000 | +59.1% | 2,502 | +71.8% | 0.00% | +100.0% |
| Q4 2015 | $225,000 | +1507.1% | 1,456 | +1356.0% | 0.00% | – |
| Q3 2015 | $14,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2015 | $14,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2015 | $14,000 | -6.7% | 100 | 0.0% | 0.00% | – |
| Q4 2014 | $15,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q3 2014 | $15,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 85,205 | $9,416,000 | 7.01% |
| FORT, L.P. | 149,014 | $16,468,000 | 5.67% |
| Strategic Global Advisors, LLC | 80,231 | $11,336,000 | 4.23% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 701,900 | $77,567,000 | 3.19% |
| Ativo Capital Management LLC | 78,727 | $8,700,000 | 2.01% |
| Analyst IMS Investment Management Services Ltd. | 31,438 | $3,474,000 | 1.47% |
| Parametrica Management Ltd | 4,327 | $478,000 | 1.32% |
| Freestone Capital Holdings, LLC | 89,005 | $9,836,000 | 0.90% |
| RPG Investment Advisory, LLC | 19,580 | $2,163,000 | 0.68% |
| MERITAGE PORTFOLIO MANAGEMENT | 38,465 | $4,251,000 | 0.47% |